Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    These changes are minor textual updates to the PubMed publications notes and revision labels, with no impact on study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:25:15.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The government operating status notice about funding has been removed, while the core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:10:57.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The Study Details page shows cosmetic/UI adjustments to layout with no changes to core study information such as eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:08:20.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Update includes a funding/status notice and a version bump to v3.2.0; the previous v3.1.0 reference was removed.
    Difference
    3%
    Check dated 2025-10-06T05:47:36.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:50.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    This is a minor update: the revision is updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. No changes were made to core content, pricing, stock, or time-slot information.
    Difference
    0.2%
    Check dated 2025-09-14T20:02:22.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.